Luminate Medical
PrivateLast Round
Series A
Extension
Jan 7, 2026
Est. Valuation
$78M
Total Funding Raised
$68.94M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Luminate Medical is a medical technology company that develops wearable devices and services to prevent chemotherapy side effects and enable at-home cancer care.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Patient Engagement
Business Model
B2B2C
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Luminate Medical Comparables
Compare Luminate Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cooler Heads Care | 90% | |
| Paxman AB | 83% | |
| Penguin Cold Caps | 74% |
Luminate Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 7, 2026 | ||||
| Grant | Apr 23, 2025 | ||||
| Series A Extension | Dec 4, 2024 | ||||
| Series A | Sep 19, 2024 | ||||
| Grant | Nov 23, 2023 | ||||
Grant | Jun 20, 2023 |
Key People
Founding team and executive leadership
Luminate Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Atlantic Bridge Capital | Series A Extension, Series A |
| European Innovation Council Fund | Grant |
| Gaingels | Series A |
| ARTIS Ventures | Series A Extension, Series A |
| Y Combinator | Accelerator, Series A Extension |
| Faber Ventures | Series A Extension, Series A, Seed |
| Elkstone | Series A Extension, Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 23, 2026
Grew 24% QoQ, from 50 to 62 employees.
- Apr 23, 2026
Grew 16% QoQ from 51 to 59 employees.
Luminate Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Luminate Medical's valuation, stock price, and market status.
Is Luminate Medical a public or private company?
Luminate Medical is a private company.
What is the current stock price of Luminate Medical?
Luminate Medical is a private company with no public stock price. No recent secondary market data is available.
How much is Luminate Medical worth (valuation)?
Luminate Medical's valuation is estimated at $75.0M based on funding round data.
Can I buy Luminate Medical stock?
Luminate Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Luminate Medical's last funding round?
Luminate Medical's most recent funding round was Series A on December 4, 2024.
Who are the main investors in Luminate Medical?
Key investors in Luminate Medical include ARTIS Ventures, SciFounders.
Will Luminate Medical IPO soon?
No public IPO plans have been announced for Luminate Medical.
How can I track Luminate Medical secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Luminate Medical's secondary market activity and sign up for updates.